Jul 3, 2024, 12:06
Guillermo Villacampa presents the HER2DX assay and its impact on survival outcomes
ESMO shared on LinkedIn:
“For ESMO members: Breaking Science in breast cancer. Guillermo Villacampa presents the HER2DX assay and its impact on survival outcomes.
Discover this video and more in the series on OncologyPRO now.”
Source: ESMO/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19